Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-13

Clinical Trial Update: Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)

View source ↗

Summary

Clinical trial update on the AMICA study examining patterns of ABL mutations in Asian patients with imatinib-resistant chronic myeloid leukemia and Philadelphia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imatinib (imatinib)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Chronic Myeloid Leukemia or Ph Positive ALL | Status: UNKNOWN